Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1039

1.

Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.

Zapolski T, Waciński P, Kondracki B, Rychta E, Buraczyńska MJ, Wysokiński A.

Kardiol Pol. 2011;69(4):319-26.

2.

Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis.

Coutinho Tde A, Turner ST, Peyser PA, Bielak LF, Sheedy PF 2nd, Kullo IJ.

Am J Hypertens. 2007 Jan;20(1):83-9.

PMID:
17198917
3.

Uric acid as a marker for renal dysfunction in hypertensive women on diuretic and nondiuretic therapy.

Borges RL, Hirota AH, Quinto BM, Ribeiro AB, Zanella MT, Batista MC.

J Clin Hypertens (Greenwich). 2009 May;11(5):253-9.

PMID:
19534022
4.
5.

Association of uric acid with risk factors for chronic kidney disease and metabolic syndrome in patients with essential hypertension.

Seki S, Tsutsui K, Fujii T, Yamazaki K, Anzawa R, Yoshimura M.

Clin Exp Hypertens. 2010;32(5):270-7. doi: 10.3109/10641960903265220.

PMID:
20662727
6.

Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.

Bianchi C, Penno G, Malloggi L, Barontini R, Corfini M, Giovannitti MG, Di Cianni G, Del Prato S, Miccoli R.

Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):31-8. Epub 2007 Apr 8.

PMID:
17420118
8.

Elevated serum leptin concentrations in women with hyperuricemia.

Matsubara M, Chiba H, Maruoka S, Katayose S.

J Atheroscler Thromb. 2002;9(1):28-34.

9.

Measures of obesity and metabolic syndrome in Indian Americans in northern California.

Misra KB, Endemann SW, Ayer M.

Ethn Dis. 2006 Spring;16(2):331-7.

PMID:
17682232
10.

Serum uric acid is a determinant of metabolic syndrome in a population-based study.

Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Sari I, Yazici M, Keleş I.

Am J Hypertens. 2006 Oct;19(10):1055-62.

PMID:
17027827
11.

Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus.

Mojiminiyi OA, Abdella NA.

Scand J Clin Lab Invest. 2007;67(2):215-25.

PMID:
17366001
12.
13.

Meal testing and postprandial state of type 2 diabetic patients with metabolic syndrome.

Brădescu OM, Georgescu M, Ifrim S, Ioacără S, Ionescu-Tîrgovişte C.

Rom J Intern Med. 2005;43(1-2):97-113.

PMID:
16739870
14.
15.

Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.

De Pergola G, De Mitrio V, Sciaraffia M, Pannacciulli N, Minenna A, Giorgino F, Petronelli M, Laudadio E, Giorgino R.

Metabolism. 1997 Nov;46(11):1287-93.

PMID:
9361687
16.

Ten-year change in serum uric acid and its relation to changes in other metabolic risk factors in young black and white adults: the CARDIA study.

Rathmann W, Haastert B, Icks A, Giani G, Roseman JM.

Eur J Epidemiol. 2007;22(7):439-45. Epub 2007 May 5.

PMID:
17484024
17.

Association between fasting glucose and C-reactive protein in middle-aged subjects.

Aronson D, Bartha P, Zinder O, Kerner A, Shitman E, Markiewicz W, Brook GJ, Levy Y.

Diabet Med. 2004 Jan;21(1):39-44.

PMID:
14706052
18.

Metabolic syndrome risk factors and estimated glomerular filtration rate among children and adolescents.

Koulouridis E, Georgalidis K, Kostimpa I, Koulouridis I, Krokida A, Houliara D.

Pediatr Nephrol. 2010 Mar;25(3):491-8. doi: 10.1007/s00467-009-1364-x. Epub 2009 Dec 10.

PMID:
20012104
19.

Body mass and atherogenic dyslipidemia as major determinants of blood levels of B-type natriuretic peptides in Arab subjects with acute coronary syndromes.

Akanji AO, Suresh CG, Al-Radwan R, Fatania HR.

Metab Syndr Relat Disord. 2009 Dec;7(6):563-9. doi: 10.1089/met.2009.0034.

PMID:
19642911
20.

An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis.

Stompór T, Pasowicz M, Sulłowicz W, Dembińska-Kieć A, Janda K, Wójcik K, Tracz W, Zdzienicka A, Klimeczek P, Janusz-Grzybowska E.

Am J Kidney Dis. 2003 Jan;41(1):203-11.

PMID:
12500238

Supplemental Content

Support Center